Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome

scientific article

Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ANA.24166
P932PMC publication ID4084968
P698PubMed publication ID24771589

P50authorGeorge HripcsakQ32634180
Jan ClaassenQ89261556
Mitchell S V ElkindQ90764032
David AlbersQ91664531
Deborah PuginQ95316367
Neeraj BadjatiaQ97531471
Sachin AgarwalQ104434119
Stephan A. MayerQ111584599
J. Michael SchmidtQ43182649
Gian Marco De MarchisQ57009501
E. Sander ConnollyQ72655267
P2093author name stringVanja Dukic
Serge Cremers
Christina Maria Falo
P2860cites workTNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseQ21093232
Tirilazad for aneurysmal subarachnoid haemorrhageQ24240010
Tumor necrosis factor receptor levels are associated with carotid atherosclerosisQ28344629
A comparison of methods to test mediation and other intervening variable effectsQ29010534
SPSS and SAS procedures for estimating indirect effects in simple mediation modelsQ29030367
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceQ29618757
Sterile inflammation: sensing and reacting to damageQ29620014
The immunology of stroke: from mechanisms to translationQ29620066
Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studiesQ30436554
Antagonism of peripheral inflammation reduces the severity of status epilepticus.Q30498265
Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomesQ30544942
Examination of Several Potential Mechanisms for the Negative Outcome in a Clinical Stroke Trial of Enlimomab, a Murine Anti-Human Intercellular Adhesion Molecule-1 Antibody: A Bedside-to-Bench StudyQ31028414
The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrumQ81521902
Blood–brain barrier dysfunction and epilepsy: Pathophysiologic role and therapeutic approachesQ33354141
Brain interstitial fluid TNF-alpha after subarachnoid hemorrhageQ33712587
A randomized trial for the treatment of refractory status epilepticus.Q34024128
DAMPening inflammation by modulating TLR signallingQ34035570
EFNS guideline on the management of status epilepticus in adultsQ34091095
Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophyQ34125516
IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytesQ34306350
A novel immune-based therapy for stroke induces neuroprotection and supports neurogenesisQ34607424
Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoringQ35141984
TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1.Q35320816
A genomic storm in critically injured humansQ35627656
Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology.Q36837023
Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammationQ36964367
Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures.Q37058086
Resuscitation and critical care of poor-grade subarachnoid hemorrhageQ37400544
Guidelines for the evaluation and management of status epilepticusQ38004984
Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhageQ39845657
Serum neuron-specific enolase in the major subtypes of status epilepticusQ41613718
Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathologyQ41614701
Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisisQ42004329
Acute systemic inflammatory response syndrome in subarachnoid hemorrhageQ43730484
Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke AssociationQ45733407
Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcomeQ46127424
Refractory status epilepticus: effect of treatment aggressiveness on prognosisQ46802749
Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1raQ46923745
Acute-phase proteins and mortality in status epilepticus: a 5-year observational cohort studyQ48120156
Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis studyQ48339631
Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.Q48429793
Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brainQ48502190
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhageQ48504182
Continuous electroencephalography in the medical intensive care unitQ48650666
Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageQ49047694
Is circulating tumor necrosis factor bioactive?Q67938701
The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunctionQ77439598
P4510describes a project that usesSQLQ47607
P433issue5
P921main subjectsubarachnoid hemorrhageQ693442
P304page(s)771-781
P577publication date2014-05-16
P1433published inAnnals of NeurologyQ564414
P1476titleNonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome
P478volume75